Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis Through Toll-Like Receptor 4 Pathways

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.116.239137
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)